Acadia Healthcare Company, Inc. current report, 25 April 2012

Acadia Healthcare Company, Inc. - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed on April 27, 2012, covering events that occurred on April 25, 2012. The filing details significant changes to the Company's Board of Directors and executive leadership, as well as amendments to existing stockholder and employment agreements.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes.

Material Changes Versus Prior Period

  • Board of Directors: Gary A. Mecklenburg resigned as a Class II director. Five new directors were elected: Matthew W. Clary, David O. Neighbours, and Eric S. Gordon (Class I); Christopher J. Graber and Bradley M. Eckmann (Class II). All new directors are affiliated with Waud Capital Partners, L.L.C.
  • Lead Director: Reeve B. Waud was appointed as Lead Director.
  • Executive Officers: Brent Turner was elected President, succeeding Norman K. Carter III, who resigned. Karen M. Prince also resigned from her positions as Division President and former Chief Operating Officer.
  • Agreements: Amendments were made to the Employment Agreements of Mr. Carter and Ms. Prince, reducing non-compete restrictions from 12 months to 6 months. An amendment to the Stockholders Agreement was also executed to allow Mr. Carter and Ms. Prince to sell up to 50,000 shares of common stock per 90-day period starting April 25, 2013.

Guidance, Outlook, and Risks

The filing does not contain financial guidance, outlook, or management commentary regarding future performance. The resignations of Mr. Carter and Ms. Prince were not the result of any disagreement with the Company. The filing notes that committee assignments for the newly elected directors are not yet determined.

Key Facts for Investor Verification

  • Confirm the extent of Waud Capital Partners' influence on the Board following the election of five affiliated directors.
  • Verify the transition plan for Brent Turner as the sole President following the departure of the Co-Presidents.
  • Monitor the potential impact of the amended Stockholders Agreement on share liquidity for former executives starting in April 2013.
  • Review the upcoming 2012 annual meeting of stockholders scheduled for May 23, 2012, for the re-election of Class I directors.